Without partnerships, much – potentially all – global health work would be fruitless. That is why we decided to catch up with one of our …
By Dave Ross, ScD President and Chief Executive Officer, The Task Force for Global Health The Task Force was originally conceived to bring together the
Teri McClure, JD, a senior executive at United Parcel Service (UPS), has been named chair of The Task Force for Global Health Board of Directors.
A new research project in Ethiopia is evaluating a diagnostic test for determining whether trachoma, the leading cause of infectious blindness, has been eliminated within
Patrick Lammie, PhD, chief scientist for The Task Force’s Neglected Tropical Diseases Support Center, was recently honored with two prestigious awards from the Centers for
An estimated 0.8 percent of people with certain primary immune deficiency diseases (PIDs) excrete poliovirus for prolonged periods after receiving oral polio vaccine, according to
By Dr. Dionisio Herrera Guibert, Director of TEPHINET I recently attended a graduation ceremony in Haiti for 25 field epidemiologists who completed a training program
Task Force President and Chief Executive Officer (CEO) Dave Ross, ScD, is among 15 public health champions who have been recognized as “Georgia Giants in
For the first time, Kenya now has a complete picture of its healthcare workforce, which will help officials address critical shortages and uneven distribution of
By Meg Farrell, MPH, Polio Eradication Support, The Task Force for Global Health I recently had the opportunity to travel to Nigeria to help assess
The Hilton Prize Coalition’s Leading Thoughts series provides a glimpse into the approaches driving recipients of the Conrad N. Hilton Humanitarian Prize. In this video,
Building on the success of the first-ever massive online course (MOOC) on trachoma elimination, The Task Force’s International Trachoma Initiative (ITI) and partners are now
Header photo caption: A drug distributor travels long distances to a remote village in Cameroon to get medicines for onchocerciasis (river blindness) and lymphatic filariasis to marginalized societies most in need.